Tonghua Golden-Horse Pharmaceutical Industry (SHE:000766) attributable profit rose 16% to 12.5 million yuan in the first half from 77.7 million yuan in the year-ago period, according to a Wednesday filing with the Shenzhen Stock Exchange.
Earnings per share at the pharmaceutical company increased 15% to 0.0129 yuan from 0.0112 yuan in the previous year.
Revenue declined 11% to 649.2 million yuan from 728.5 million yuan a year earlier.
Shares fell 4% during Wednesday's afternoon trading.
Price (RMB): ¥13.01, Change: ¥-0.59, Percent Change: -4.34%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments